We are at the forefront of educating health care professionals about our marketed products so that they can choose the most appropriate treatment for their patients. We collaborate closely with marketing, access and medical teams to drive innovation in bringing treatment to our patients. Our field force is critical in achieving our ambition of positively impacting our patient’s lives now and into the future.
We are committed to bringing more of our medicines to more people, regardless of where they are. In fact, it is one of our core 5 key strategies. We have established the Novartis Access Principles in order to help us drive that commitment. These strategies include adopting innovative pricing and access models, refocusing research and development based on society’s healthcare needs, and supporting approaches to strengthen healthcare systems. For all our new medicines, we systematically integrate access strategies in how we research, develop and deliver globally. We help design and deliver innovative approaches to drive better outcomes and affordable solutions and this is the key measure to our success.
Sandoz, the generics arm of Novartis, fundamentally believes that health outcomes for patients can be improved everywhere if more people are trained to prevent, diagnose and treat disease and if the right medicines get to more people.
The Sandoz Healthcare Access Challenge invites entrepreneurs and innovators in the field of digital technology to submit ideas with the potential to complement - or even positively disrupt - established approaches to driving access to healthcare.
Sandoz is determined to play a leading role in driving access to global healthcare by focusing on areas of unmet medical need. Sandoz sees the future of medicine as driven by increasingly strong collaboration between healthcare companies and external partners, and the goal of Sandoz HACk is to help make this vision a reality - by identifying and supporting small, practical ideas with the potential to spark big change.
We seek out the patient’s perspective in everything we do. We collaborate with Medical, Access, Digital and Sales to support local, regional and global marketing long and short-term product strategies. Drive the evolution of the go-to-market model through innovative digital solutions and strategies that puts the patient right at the center. Be a part of our marketing transformation plan to become a best-in-class marketing organization.
Build long-term partnerships to access therapeutic products, technology platforms and break through innovations with the potential to prevent and cure diseases, to ease suffering and to enhance the quality of life. Create long-term shareholder value by refocusing our pipeline to the strategic priorities through divestments of assets. Build a wide network within the life sciences community to gain access to new innovation and to explore opportunities in our core strategic areas, as well as outside, which have the potential to set our future direction.
The BD&L team members are embedded within each group at Novartis to gain an understanding of our latest research and development efforts, and paths to commercialization. Be a part of the team behind some of our most notable partnerships. BD&L is a unique group at Novartis that serves as a conduit, bringing external innovation into our organization in the form of business partnerships. The ultimate goal of the relationships developed with outside organizations is to get the right treatments to the right patients at the right time.